Recent epidemics have shown how important it is to have effective, rapid and inexpensive diagnostic tools available in sufficient numbers to detect the responsible pathogens in all populations, including the most vulnerable, to improve the clinical management of patients and to guarantee a healthy life for all.
The aim of the ACDx course is to promote the role and value of medical diagnostics in relation to public health issues such as antimicrobial resistance, the fight against epidemics and climate change. It is crucial to strengthen the decision-making capacity of public health scientists and decision-makers, particularly in developing countries, through training and the creation of partnerships and networks.
This week-long intensive course is led by Dr Joseph Tucker from the London School of Hygiene & Tropical Medicine (LSHTM) and Dr. François-Xavier Babin from the Mérieux Foundation. The program is developed with a Steering Committee comprising representatives from Africa CDC, Clinton Health Access Initiative (CHAI), Foundation for Innovative New Diagnostics (FIND), Gates Foundation, Global Fund, UNICEF, Unitaid, University of North Carolina, US Centers for Disease Control and Prevention (CDC) and WHO.
Each year, ACDx welcomes around 30 English-speaking participants from the worlds of science, academia, industry and governmental and non-governmental organizations. Some of them receive fellowships to take part in the course and all join an active community now made up of over 400 alumni.
Course fees
Accommodation
- All participants (includes 3 meals a day for the full period of the course): €1,800*
Registration
- Participants from academic, government institutions & NGOs: €1,900*
- Other industry participants: €3,000*
*VAT included. All fees are due in full to confirm participation.
